Background:Chemoprevention effect of aspirin for pancreatic cancer(PC)remains unclear.Here we performed an updated systematic review and meta-analysis to investigate the real association between aspirin consumption an...Background:Chemoprevention effect of aspirin for pancreatic cancer(PC)remains unclear.Here we performed an updated systematic review and meta-analysis to investigate the real association between aspirin consumption and risk of PC.Methods:PubMed,Web of Science,EMBASE and the Cochrane Database were systematic searched to identify the potential studies.Odds ratio(ORs)with 95%confidence intervals(CIs)were applied to assess the strength of associations.Results:Thirteen studies and approximately 28,440 participants were included.Aspirin significantly reduced the incidence of PC(OR,0.82;95%CI,0.73-0.93)in case-control studies.However,the overall results did not reveal an obvious association(OR,0.92;95%CI,0.74-1.16).Both low-dose(OR=0.86)and high-dose(OR=0.80)aspirin intake showed prevention effect.In addition,low frequency(OR,0.87;95%CI,0.73-1.05)and high frequency(OR,0.84;95%CI,0.69-1.03)seemed to be equally associated with decreased risk for PC.Aspirin consumption longer than 10 years use seems to have better effect(OR,0.73;95%CI,0.51-1.04)than shorter aspirin use(OR,0.94;95%CI,0.77-1.15).Conclusions:Our study indicated that aspirin use might be associated with decreased risk of PC,especially at high doses.But we still need to be cautious when interpreting the results.展开更多
基金supported by the National Natural Science Foundation of China(81972274,81900731,81702365)Shandong Provincial Natural Science Foundation,China(ZR2017MH090)support by China Scholarship Council for a visiting scholarship(CSC 201806225020).
文摘Background:Chemoprevention effect of aspirin for pancreatic cancer(PC)remains unclear.Here we performed an updated systematic review and meta-analysis to investigate the real association between aspirin consumption and risk of PC.Methods:PubMed,Web of Science,EMBASE and the Cochrane Database were systematic searched to identify the potential studies.Odds ratio(ORs)with 95%confidence intervals(CIs)were applied to assess the strength of associations.Results:Thirteen studies and approximately 28,440 participants were included.Aspirin significantly reduced the incidence of PC(OR,0.82;95%CI,0.73-0.93)in case-control studies.However,the overall results did not reveal an obvious association(OR,0.92;95%CI,0.74-1.16).Both low-dose(OR=0.86)and high-dose(OR=0.80)aspirin intake showed prevention effect.In addition,low frequency(OR,0.87;95%CI,0.73-1.05)and high frequency(OR,0.84;95%CI,0.69-1.03)seemed to be equally associated with decreased risk for PC.Aspirin consumption longer than 10 years use seems to have better effect(OR,0.73;95%CI,0.51-1.04)than shorter aspirin use(OR,0.94;95%CI,0.77-1.15).Conclusions:Our study indicated that aspirin use might be associated with decreased risk of PC,especially at high doses.But we still need to be cautious when interpreting the results.
